Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosi
about
Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cellsGemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cellsThe O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancerSynthesis and in vitro evaluation of 5-[(18)f]fluoroalkyl pyrimidine nucleosides for molecular imaging of herpes simplex virus type 1 thymidine kinase reporter gene expression.Current prodrug strategies via membrane transporters/receptors.Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes.Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancersA metal-containing nucleoside that possesses both therapeutic and diagnostic activity against cancerNucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy.A conformationally mobile cysteine residue (Cys-561) modulates Na+ and H+ activation of human CNT3Challenges for the development of ribonucleoside analogues as inducers of error catastrophe.A novel (11)C-labeled thymidine analog, [(11)C]AZT, for tumor imaging by positron emission tomography.Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma UndergoiTreatment of pancreatic cancer: what can we really predict today?Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment Decisions.Effect of genotype on duodenal expression of nutrient transporter genes in dairy cows.Uptake carriers and oncology drug safety.Challenges of drug resistance in the management of pancreatic cancer.Translocation of nucleoside analogs across the plasma membrane in hematologic malignancies.ABC transporters and their role in nucleoside and nucleotide drug resistance.Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives.Pancreatic cancer - cost for overtreatment with gemcitabine.Adjuvant pharmacotherapy in the management of elderly patients with pancreatic cancer.Membrane drug transporters and chemoresistance in human pancreatic carcinoma.Hypoxia and P1 receptor activation regulate the high-affinity concentrative adenosine transporter CNT2 in differentiated neuronal PC12 cells.An integrative network inference approach to predict mechanisms of cancer chemoresistance.Differential regulation of mouse equilibrative nucleoside transporter 1 (mENT1) splice variants by protein kinase CK2.Identification of AtENT3 as the main transporter for uridine uptake in Arabidopsis roots.Homo- and heteroexchange of adenine nucleotides and nucleosides in rat hippocampal slices by the nucleoside transport system.Exploring the Potent Inhibition of CTP Synthase by Gemcitabine-5'-Triphosphate.Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides.Nucleoside transporter gene expression in wild-type and mENT1 knockout mice.p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
P2860
Q27690256-D95E7FE4-395D-43FB-B046-B8670789F05AQ28570384-3753B8C8-FC6A-4BD1-996D-38DCEC512CC2Q29937967-F3358513-DD0F-41C6-8AE7-D7D7611800C0Q33597112-3F6EA9A5-8CB4-4A33-AA07-EBFB6A9C9412Q34005456-E3898C26-AF5C-430F-BA6F-28D03C188DFFQ34779782-6DD765FD-A3F2-422A-B2D4-A15F03620B17Q35003182-B9D8C7B7-AA2F-4ACC-B55D-7B2EC75C8735Q35066350-EF685A28-96DB-4A60-9CD6-295E0CEECF43Q35318609-412ED305-F63F-4C7C-BB7A-1D083112E47BQ35351955-F56090E0-B574-479B-A7C8-A54808C7C1DEQ35567292-6DB0F289-B4AA-4DCA-B7DC-9392EDFDA740Q35676740-E533F568-4AB4-4304-A932-ECE6A7685B2DQ35742174-0BFFAC32-0292-4992-8BB8-A8C54EDDD496Q36134948-8D907639-6EB2-4D1A-9846-A09F75B28CB8Q36302124-C01C247E-A200-4530-966E-86135C645ED1Q36822149-E82D5EAF-A085-41FF-936C-5D59B34B43D1Q37129815-5E925793-D415-4C80-9B84-2419DC7D4EB9Q37342736-F7B79570-119D-405A-9F35-8F5911958FE4Q37434377-E04725A5-E5D1-4928-8131-1A11ED639639Q37663396-CEF67FF4-5314-46E2-BB2B-ABA39A0E6F78Q37799830-3392BF5C-31E6-4F6D-A88E-F80516613D56Q37963498-DBDB50B0-C6F2-4791-9620-3FA81F08A9E7Q37979617-920DE780-4784-4702-9749-2427E0F910BFQ38058785-B1742F9D-6FC3-4F95-AB9B-F034CC084C89Q38067828-14C85258-3639-43A7-8D3D-24E9FCF6E5B9Q38075827-585765F3-A793-4E08-9B48-706EE0EE1B4DQ38161328-168CA2F5-7258-4147-8D96-5A4B6A6CEC7EQ39131639-E95774B8-FD20-4A7E-BE5A-AA57E676238DQ39206497-F1800780-2067-435A-A457-2997B1A349B5Q40129083-140DC571-B8B1-4A38-A806-077472D583EAQ40333894-A6BAF136-545B-4C83-BCC7-DEDA6DB61DE9Q43263363-37F97DFE-2E10-4F4B-BF22-F6B0E7F85EFFQ46215323-9DC4AD90-F088-4341-8B49-CB758D67E76EQ49929146-17A46549-E89E-4393-9C64-6AE7F71E38E9Q52609625-2B94FA35-B7B3-4281-AD0E-A298D123E018Q58760423-BCB6408C-75E7-44F6-A09C-35E8BE7084C7
P2860
Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosi
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Recent molecular advances in s ...... purine and pyrimidine nucleosi
@ast
Recent molecular advances in s ...... purine and pyrimidine nucleosi
@en
type
label
Recent molecular advances in s ...... purine and pyrimidine nucleosi
@ast
Recent molecular advances in s ...... purine and pyrimidine nucleosi
@en
prefLabel
Recent molecular advances in s ...... purine and pyrimidine nucleosi
@ast
Recent molecular advances in s ...... purine and pyrimidine nucleosi
@en
P2093
P1476
Recent molecular advances in s ...... purine and pyrimidine nucleosi
@en
P2093
Baldwin SA
Karpinski E
P356
10.1080/09687680010026313
P577
2001-01-01T00:00:00Z